LMP-2 expressing T cell gene therapy (University College London)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLMP-2 expressing T cell gene therapy (University College London)
Drug Alias NameT cell receptor (UCLB)Latent Membrane Protein-2 expressing T cell gene therapy (University College London)
ClassificationBiologics
Mechanisms of ActionT-cell receptor modulators
TargetsT-cell receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUCL Business PLCUniversity College London
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A